Loading: 100%
Neurocrine Biosciences Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 400 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker NBIXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 173040506070
datesClosing price (adj.)
13.10.201762.15
11.10.201761.86
04.10.201762.56
27.09.201758.74
20.09.201756.80
13.09.201757.41
06.09.201758.64
30.08.201753.80
23.08.201751.98
16.08.201753.55
09.08.201754.78
02.08.201748.56
26.07.201749.00
19.07.201747.73
12.07.201746.26
05.07.201747.99
27.06.201745.56
20.06.201745.67
13.06.201744.23
06.06.201745.48
30.05.201743.52
23.05.201753.53
16.05.201753.93
09.05.201752.60
02.05.201753.83
25.04.201753.62
18.04.201752.06
11.04.201741.48
04.04.201743.22
28.03.201741.64
21.03.201741.77
14.03.201745.58
07.03.201743.49
28.02.201744.16
21.02.201743.90
14.02.201741.53
07.02.201743.60
31.01.201742.91
24.01.201740.12
17.01.201740.17
10.01.201742.61
03.01.201738.66
27.12.201638.31
19.12.201640.60
12.12.201642.01
05.12.201643.61
28.11.201649.19
21.11.201650.89
14.11.201654.77
07.11.201644.13
31.10.201643.77
24.10.201645.06
17.10.201642.30
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
62.15n/a
Market Capitalisation
in million USD
5,474n/a
Enterprise Value
in million USD
5,242n/a
Common Shares Outstanding
as per May 3, 2017
88,074,963n/a
Preferred Shares Outstanding
as per May 3, 2017
n/a
Average Basic Shares Outstanding
TTM
86,909,500n/a
Average Diluted Shares Outstanding
TTM
86,713,000n/a
Index Membership
n/a
Business Summary
Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 236n/a
Receivables 0n/a
Total Current Assets 239n/a
PP&E 7n/a
Total Assets 289n/a
Accounts Payable 1n/a
Current Debt 4n/a
Total Current Liabilities 24n/a
Long-Term Debt 0n/a
Total Liabilities 42n/a
Total Equity 247n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital 17n/a
Operating Cash Flow -154n/a
Net Change in PP&E and Intangibles -5n/a
Investing Cash Flow 99n/a
Dividends Paid 0n/a
Financing Cash Flow 4n/a
Total Change in Cash -51n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 2.84n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 21.86n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.05n/a
Other Ratios
Current Ratio 1,016.2%n/a
Liabilities to Equity Ratio 17.1%n/a
Debt to Assets Ratio 1.4%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
3
34
77
53
3
0
20
15
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
3
34
77
53
3
0
20
15
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-54
-47
-43
-52
-53
-64
-114
-162
Selling, General & Administrative
-14
-13
-12
-13
-13
-18
-32
-68
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-34
-31
-31
-37
-39
-46
-81
-94
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
-6
-3
0
-1
0
0
0
0
Operating Income (Loss)
-51
-14
34
1
-50
-64
-94
-147
Non-Operating Income (Loss)
-1
3
0
1
0
1
2
3
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
-1
2
0
0
0
1
2
3
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
1
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-52
-11
34
2
-49
-64
-92
-145
Abnormal Gains (Losses)
-6
-3
-3
-3
-3
-3
-3
-3
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-58
-14
31
-1
-52
-67
-96
-148
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-58
-14
31
-1
-52
-67
-96
-148
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-58
-14
31
-1
-52
-67
-96
-148
Minority Interest
0
0
0
0
0
0
0
0
Net Income
-58
-14
31
-1
-52
-67
-96
-148
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-58
-14
31
-1
-52
-67
-96
-148
Remarks
restated on Feb 9, 2012 n/a
calculated values,
restated on Feb 8, 2013 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 9, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
127
129
173
146
194
379
307
Cash & Cash Equivalents
n/a
54
50
64
45
31
74
83
Short Term Investments
n/a
73
79
109
101
163
305
224
Accounts & Notes Receivable
n/a
4
2
14
0
0
0
0
Accounts Receivable, Net
n/a
4
2
14
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
2
1
2
3
4
5
3
Prepaid Expenses
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
2
1
2
3
4
5
3
Total Current Assets
n/a
133
132
189
148
198
384
310
Property, Plant & Equipment, Net
n/a
2
2
2
2
3
3
6
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
4
0
0
0
37
82
43
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
6
4
4
4
5
5
5
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
6
4
4
4
5
5
5
Total Noncurrent Assets
n/a
11
6
7
6
45
91
55
Total Assets
n/a
144
138
196
155
243
475
365
Liabilities and owners' equity
Payables & Accruals
n/a
9 9413000
10 9562000
9 9005000
8 8056000
12 11754000
22 21595000
26 26182000
Accounts Payable
n/a
1 810000
1 1111000
1 911000
0 101000
0 246000
3 2561000
5 5085000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
9 8603000
8 8451000
8 8094000
8 7955000
12 11508000
19 19034000
21 21097000
Short Term Debt
n/a
40 39979000
37 37284000
6 6052000
3 3227000
3 3443000
4 3692000
4 3996000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
3 3385000
0 264000
1 589000
0 416000
0 467000
0 428000
0 236000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
3 3385000
0 264000
1 589000
0 416000
0 467000
0 428000
0 236000
Total Current Liabilities
n/a
53 52777000
47 47110000
16 15646000
12 11699000
16 15664000
26 25715000
30 30414000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
72 72302000
31 31177000
26 25961000
23 22567000
19 18670000
25 24616000
20 19795000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
37 37162000
3 2919000
0 0
0 0
0 0
10 10231000
10 10231000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
35 35140000
28 28258000
26 25961000
23 22567000
19 18670000
14 14385000
10 9564000
Total Noncurrent Liabilities
n/a
72 72302000
31 31177000
26 25961000
23 22567000
19 18670000
25 24616000
20 19795000
Total Liabilities
n/a
125 125079000
78 78287000
42 41607000
34 34266000
34 34334000
50 50331000
50 50209000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
782 781662000
785 784866000
874 874047000
886 886168000
1,035 1035281000
1,341 1340665000
1,372 1371519000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-762 -762269000
-725 -724698000
-720 -719673000
-766 -765763000
-826 -826305000
-915 -915234000
-1,056 -1056324000
Other Equity
n/a
0 -48000
0 -87000
0 -2000
0 5000
0 -277000
-1 -977000
0 -318000
Equity Before Minority Interest
n/a
19 19345000
60 60081000
154 154372000
120 120410000
209 208699000
424 424454000
315 314877000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
19 19345000
60 60081000
154 154372000
120 120410000
209 208699000
424 424454000
315 314877000
Total Liabilities & Equity
n/a
144 144424000
138 138368000
196 195979000
155 154676000
243 243033000
475 474785000
365 365086000
Remarks restated on n/a restated on Feb 9, 2012 n/a restated on Feb 8, 2013 n/a restated on Feb 11, 2014 n/a restated on Feb 9, 2015 n/a restated on Feb 11, 2016 n/a restated on Feb 14, 2017 n/a restated on May 9, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-51
-8
38
5
-46
-61
-89
-141
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
3
1
1
1
1
1
1
1
Non-Cash Items
4
0
0
2
4
7
25
25
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-9
56
-39
-43
12
5
25
8
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-53
50
-1
-35
-30
-47
-38
-106
Change in Fixed Assets & Intangibles
1
0
-1
-1
-1
-2
-2
-4
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
11
-55
-5
-34
6
-103
-194
117
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
2
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
12
-55
-4
-35
5
-105
-196
113
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
10
21
0
84
5
139
277
2
Increase in Capital Stock
10
21
0
84
5
139
277
2
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
10
21
0
84
5
139
277
2
Net Cash Before Disc. Operations and FX
-31
17
-4
14
-19
-14
43
9
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
-31
17
-4
14
-19
-14
43
9
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
-31
17
-4
14
-19
-14
43
9
Remarks
restated on Feb 9, 2012 n/a
calculated values,
restated on Feb 8, 2013 n/a
calculated values,
restated on Feb 11, 2014 n/a
calculated values,
restated on Feb 9, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo